Evidence map›Paper›PMID 35731505›Full record

ArticleTransboundary and emerging diseases2022

Genomic characterization of Tenacibaculum maritimum O-antigen gene cluster and development of a multiplex PCR-based serotyping scheme.

Pierre Lopez, Sébastien Bridel, Denis Saulnier, Rarahu David, Beatriz Magariños, Beatriz S Torres, Jean François Bernardet, Eric Duchaud

Open access · hybridAbstract read
In one paragraph

Article in Transboundary and emerging diseases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 14 citations in OpenAlex.

  1. Diversity of biofilm architectures within the genusApplied and environmental microbiology · 2026
    Article
  2. Phenotypic, Genetic, and Virulence Characterization ofPathogens (Basel, Switzerland) · 2026
    Article
  3. International journal of systematic and evolutionary microbiology · 2025
    Article
  4. Article
  5. First complete genome sequence ofMicrobiology resource announcements · 2025
    Article
  6. Article
  7. Genomics ofPathogens (Basel, Switzerland) · 2023
    Article
  8. The secretome of the fish pathogenFrontiers in cellular and infection microbiology · 2023
    Article
  9. Article
  10. Tenacibaculosis caused byFrontiers in cellular and infection microbiology · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 3 countries.

Pierre LopezIfremer, IRD, Institut Louis Malardé, Univ Polynésie Française, EIO, Labex Corail, Taravao, French Polynesia.
Sébastien BridelUniversité Paris-Saclay, INRAE, UVSQ, VIM, Jouy-en-Josas, France.
Denis SaulnierIfremer, IRD, Institut Louis Malardé, Univ Polynésie Française, EIO, Labex Corail, Taravao, French Polynesia.
Rarahu DavidDRM, Direction des Ressources Marines, Fare Ute Immeuble Le caill, Papeete, French Polynesia.ORCID https://orcid.org/0000-0002-7573-0871
Beatriz MagariñosDepartamento de Microbiología, Facultad de Biología/CIBUS, Universidad de Santiago de Compostela, Santiago de Compostela, Spain.
Beatriz S TorresDepartamento de Microbiología, Facultad de Biología/CIBUS, Universidad de Santiago de Compostela, Santiago de Compostela, Spain.
Jean François BernardetUniversité Paris-Saclay, INRAE, UVSQ, VIM, Jouy-en-Josas, France.
Eric DuchaudUniversité Paris-Saclay, INRAE, UVSQ, VIM, Jouy-en-Josas, France.ORCID https://orcid.org/0000-0003-3353-4714
Université de Versailles Saint-Quentin-en-Yvelines · FRUniversidade de Santiago de Compostela · ESInstitut Louis Malardé · PFInstitut Pasteur · FR

Funding

AAP Ressourcement Scientifique F2E 2017Agence Nationale pour la Recherche ANR-10-INBS-09Agence Nationale pour la Recherche ANR-11-INBS-0013Ifremer and the Direction des Ressources Marines (DRM) RTI2018-093634-B-C21IFREMER-DRMInstitut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement, FranceState Agency for Research (AEI) of SpainXunta de Galicia, Spain
6 · The paper itself

Abstract

Tenacibaculum maritimum is a devastating bacterial pathogen affecting a large variety of marine fish species. It is responsible for significant economic losses in aquaculture farms worldwide. Different typing methods have been proposed to analyse bacterial diversity and population structure. Serological heterogeneity has been observed and up to four different serotypes have been described so far. However, the underlying molecular factors remain unknown. By combining conventional serotyping and genome-wide association study, we identified the genomic loci likely involved in the O-antigen biosynthesis. This finding allowed the development of a robust multiplex PCR-based serotyping scheme able to detect subgroups within each serotype and therefore performs better than conventional serotyping. This scheme was successfully applied to a large number of isolates from worldwide origin and retrieved from a large variety of fish species. No obvious correlations were observed between the mPCR-based serotype and the host species or the geographic origin of the isolates. Strikingly, the distribution of mPCR-based serotypes does not follow the core genome phylogeny. Nevertheless, this simple and cost-effective mPCR-based serotyping method could be useful for different applications such as population structure analysis, disease surveillance, vaccine formulation and efficacy follow-up.

Indexed as

Fish DiseasesFlavobacteriaceae InfectionsTenacibaculumAnimalsFishesGenome-Wide Association StudyGenomicsMultigene FamilyMultiplex Polymerase Chain ReactionO AntigensSerotypingO Antigensaquaculturefish diseasesmolecular serotypingo-antigen gene clustertenacibaculosisTenacibaculum maritimum

Identifiers

PMID35731505
PMCPMC9796276
OpenAlexW4283332410

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.